HomeSUVENPHAR • NSE
add
Suven Pharmaceuticals Ltd
Previous close
₹1,178.85
Day range
₹1,151.05 - ₹1,193.95
Year range
₹528.00 - ₹1,287.90
Market cap
294.85B INR
Avg Volume
455.32K
P/E ratio
122.49
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.31B | -33.62% |
Operating expense | 734.80M | 23.33% |
Net income | 607.70M | -49.61% |
Net profit margin | 26.34 | -24.09% |
Earnings per share | — | — |
EBITDA | 794.81M | -52.13% |
Effective tax rate | 26.86% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.21B | 68.63% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 20.51B | — |
Shares outstanding | 254.27M | — |
Price to book | 14.63 | — |
Return on assets | — | — |
Return on capital | 7.86% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 607.70M | -49.61% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
1,052
